Most of papillary thyroid carcinoma has good prognosis in early stage, with a 10-year survival rate of more than 90%, while in advanced stage, the prognosis is poor and most of them are incurable. Papillary thyroid carcinoma is a common pathological type of thyroid cancer in clinic, accounting for about 70%-90%, with lower malignancy. It is mainly caused by hormones, heredity, environment and other factors, and Hashimoto’s thyroiditis may also cause papillary thyroid cancer. It often shows painless lumps in the neck, most of which move up and down with swallowing, and a few of which show hoarseness, cough, hemoptysis, bone pain, and difficulty in swallowing. Surgery, thyroid hormone treatment, isotope 131 iodine treatment, radiotherapy and chemotherapy are usually adopted in clinic. The prognosis is good after standardized treatment in early stage, while the prognosis is not good after late stage treatment, and most of them cannot be cured. Thyroid papillary carcinoma can be cured through surgical resection, and patients are advised to seek medical treatment in time to avoid delaying the condition.